E. A. Kolb

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma

R. Gorlick, R. Mason, Valerie B. Sampson, 2016, Oncotarget.

Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, is effective in pediatric solid tumors: A report by the Pediatric Preclinical Testing Consortium.

B. Teicher, P. Houghton, Malcolm A. Smith, 2022, Molecular cancer therapeutics.

BIRC5 expression is a poor prognostic marker in Ewing sarcoma

P. Garcia-Filion, D. Azorsa, P. Dickman, 2013, Pediatric blood & cancer.

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Jing Wang, A. Lazar, P. Houghton, 2022, Molecular cancer therapeutics.

p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma

R. Gorlick, V. Gopalakrishnan, E. Kolb, 2019, Scientific Reports.

The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

S. Seaman, J. Maris, B. Teicher, 2021, Clinical Cancer Research.